What to know from Robert F. Kennedy, Jr.’s hearings before the Senate Finance Committee on Wednesday and the Senate Health, Education, Labor, and Pensions on Thursday.
Robert F. Kennedy Jr.'s record of questioning childhood vaccine safety came under fire from a key Republican at the Trump HHS pick's confirmation hearing.
RFK Jr. claimed he is not “anti-vaccine” and appeared unfamiliar with key aspects of healthcare insurance programs in his confirmation hearing.
For the first time in U.S. history, a president-elect will welcome foreign leaders for one of the most American political traditions — the peaceful transfer of power. President-elect Donald Trump invited Chinese President Xi Jinping and conservative world leaders such as Argentine President Javier Milei and Italian Premier Giorgia Meloni to the
President Donald Trump has signed an order to declassify government records relating to the assassination of JFK Jr., Newsweek's live blog is closed.
If approved, Kennedy will control a $1.7 trillion agency that oversees food and hospital inspections, hundreds of health clinics, vaccine recommendations and health insurance for roughly half the country.
Robert F. Kennedy Jr. has said vaccines are not safe. His support for abortion access has made conservatives uncomfortable.
Robert F. Kennedy, President Trump’s nominee for health secretary, vigorously defended his views on vaccines, and a key senator still has clear doubts.
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. repeated claims we have written about before on vaccines and chronic disease.
Alexandra Sifferlin, a health and science editor for Times Opinion, hosted an online conversation on Wednesday with the Opinion columnist Zeynep Tufekci and the Opinion writers David Wallace-Wells and Jessica Grose about Robert F. Kennedy Jr.’s first of two confirmation hearings for secretary of health and human services.
Tulsi Gabbard, Kash Patel and Robert F. Kennedy Jr. are among Trump's more controversial nominees, and faced tough questions from senators Thursday.
The issue isn’t only his troubling views but whether a complex federal agency can function effectively under his leadership.